300 related articles for article (PubMed ID: 26431808)
1. Tau neurotoxicity and rescue in animal models of human Tauopathies.
Krüger L; Mandelkow EM
Curr Opin Neurobiol; 2016 Feb; 36():52-8. PubMed ID: 26431808
[TBL] [Abstract][Full Text] [Related]
2. Potential mechanisms and implications for the formation of tau oligomeric strains.
Gerson JE; Mudher A; Kayed R
Crit Rev Biochem Mol Biol; 2016; 51(6):482-496. PubMed ID: 27650389
[TBL] [Abstract][Full Text] [Related]
3. Tau Spreading Mechanisms; Implications for Dysfunctional Tauopathies.
Fuster-Matanzo A; Hernández F; Ávila J
Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495325
[TBL] [Abstract][Full Text] [Related]
4. Hsp90 activator Aha1 drives production of pathological tau aggregates.
Shelton LB; Baker JD; Zheng D; Sullivan LE; Solanki PK; Webster JM; Sun Z; Sabbagh JJ; Nordhues BA; Koren J; Ghosh S; Blagg BSJ; Blair LJ; Dickey CA
Proc Natl Acad Sci U S A; 2017 Sep; 114(36):9707-9712. PubMed ID: 28827321
[TBL] [Abstract][Full Text] [Related]
5. Tau pathology in Alzheimer disease and other tauopathies.
Iqbal K; Alonso Adel C; Chen S; Chohan MO; El-Akkad E; Gong CX; Khatoon S; Li B; Liu F; Rahman A; Tanimukai H; Grundke-Iqbal I
Biochim Biophys Acta; 2005 Jan; 1739(2-3):198-210. PubMed ID: 15615638
[TBL] [Abstract][Full Text] [Related]
6. Conformation determines the seeding potencies of native and recombinant Tau aggregates.
Falcon B; Cavallini A; Angers R; Glover S; Murray TK; Barnham L; Jackson S; O'Neill MJ; Isaacs AM; Hutton ML; Szekeres PG; Goedert M; Bose S
J Biol Chem; 2015 Jan; 290(2):1049-65. PubMed ID: 25406315
[TBL] [Abstract][Full Text] [Related]
7. Human cyclophilin 40 unravels neurotoxic amyloids.
Baker JD; Shelton LB; Zheng D; Favretto F; Nordhues BA; Darling A; Sullivan LE; Sun Z; Solanki PK; Martin MD; Suntharalingam A; Sabbagh JJ; Becker S; Mandelkow E; Uversky VN; Zweckstetter M; Dickey CA; Koren J; Blair LJ
PLoS Biol; 2017 Jun; 15(6):e2001336. PubMed ID: 28654636
[TBL] [Abstract][Full Text] [Related]
8. Zn
Li X; Du X; Ni J
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30678122
[TBL] [Abstract][Full Text] [Related]
9. Increase in tau tyrosine phosphorylation correlates with the formation of tau aggregates.
Vega IE; Cui L; Propst JA; Hutton ML; Lee G; Yen SH
Brain Res Mol Brain Res; 2005 Aug; 138(2):135-44. PubMed ID: 15913839
[TBL] [Abstract][Full Text] [Related]
10. Spreading of Tau Protein Does Not Depend on Aggregation Propensity.
Rodrigues S; Anglada-Huguet M; Hochgräfe K; Kaniyappan S; Wegmann S; Mandelkow EM
J Mol Neurosci; 2023 Oct; 73(9-10):693-712. PubMed ID: 37606769
[TBL] [Abstract][Full Text] [Related]
11. Tau secretion and propagation: Perspectives for potential preventive interventions in Alzheimer's disease and other tauopathies.
Annadurai N; De Sanctis JB; Hajdúch M; Das V
Exp Neurol; 2021 Sep; 343():113756. PubMed ID: 33989658
[TBL] [Abstract][Full Text] [Related]
12. Extracellular Vesicles Isolated from the Brains of rTg4510 Mice Seed Tau Protein Aggregation in a Threshold-dependent Manner.
Polanco JC; Scicluna BJ; Hill AF; Götz J
J Biol Chem; 2016 Jun; 291(24):12445-12466. PubMed ID: 27030011
[TBL] [Abstract][Full Text] [Related]
13. Glycation alter the process of Tau phosphorylation to change Tau isoforms aggregation property.
Liu K; Liu Y; Li L; Qin P; Iqbal J; Deng Y; Qing H
Biochim Biophys Acta; 2016 Feb; 1862(2):192-201. PubMed ID: 26655600
[TBL] [Abstract][Full Text] [Related]
14. Tau assemblies do not behave like independently acting prion-like particles in mouse neural tissue.
Miller LVC; Mukadam AS; Durrant CS; Vaysburd MJ; Katsinelos T; Tuck BJ; Sanford S; Sheppard O; Knox C; Cheng S; James LC; Coleman MP; McEwan WA
Acta Neuropathol Commun; 2021 Mar; 9(1):41. PubMed ID: 33712082
[TBL] [Abstract][Full Text] [Related]
15. Heterotypic seeding of Tau fibrillization by pre-aggregated Abeta provides potent seeds for prion-like seeding and propagation of Tau-pathology in vivo.
Vasconcelos B; Stancu IC; Buist A; Bird M; Wang P; Vanoosthuyse A; Van Kolen K; Verheyen A; Kienlen-Campard P; Octave JN; Baatsen P; Moechars D; Dewachter I
Acta Neuropathol; 2016 Apr; 131(4):549-69. PubMed ID: 26739002
[TBL] [Abstract][Full Text] [Related]
16. Deposition of Phosphorylated α-Synuclein in the rTg4510 Mouse Model of Tauopathy.
Takaichi Y; Ano Y; Chambers JK; Uchida K; Takashima A; Nakayama H
J Neuropathol Exp Neurol; 2018 Oct; 77(10):920-928. PubMed ID: 30107539
[TBL] [Abstract][Full Text] [Related]
17. Fungally Derived Isoquinoline Demonstrates Inducer-Specific Tau Aggregation Inhibition.
Ingham DJ; Blankenfeld BR; Chacko S; Perera C; Oakley BR; Gamblin TC
Biochemistry; 2021 Jun; 60(21):1658-1669. PubMed ID: 34009955
[TBL] [Abstract][Full Text] [Related]
18. Transcellular Spreading of Tau in Tauopathies.
Demaegd K; Schymkowitz J; Rousseau F
Chembiochem; 2018 Dec; 19(23):2424-2432. PubMed ID: 30133080
[TBL] [Abstract][Full Text] [Related]
19. The Prion-Like Behavior of Assembled Tau in Transgenic Mice.
Clavaguera F; Tolnay M; Goedert M
Cold Spring Harb Perspect Med; 2017 Oct; 7(10):. PubMed ID: 27940600
[TBL] [Abstract][Full Text] [Related]
20. A Dual Pathogenic Mechanism Links Tau Acetylation to Sporadic Tauopathy.
Trzeciakiewicz H; Tseng JH; Wander CM; Madden V; Tripathy A; Yuan CX; Cohen TJ
Sci Rep; 2017 Mar; 7():44102. PubMed ID: 28287136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
